| __timestamp | Alkermes plc | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 152500000 |
| Thursday, January 1, 2015 | 4019000 | 187800000 |
| Friday, January 1, 2016 | 2301000 | 184000000 |
| Sunday, January 1, 2017 | 7232000 | 167700000 |
| Monday, January 1, 2018 | 68895000 | 218600000 |
| Tuesday, January 1, 2019 | 52816000 | 187400000 |
| Wednesday, January 1, 2020 | 1946000 | 177700000 |
| Friday, January 1, 2021 | 1020000 | 122000000 |
| Saturday, January 1, 2022 | 393842000 | 123100000 |
| Sunday, January 1, 2023 | 270806000 | 122500000 |
| Monday, January 1, 2024 | 245326000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, innovation is key. Alkermes plc and Perrigo Company plc, two giants in the industry, have shown contrasting approaches to research and development (R&D) over the past decade. From 2014 to 2023, Perrigo consistently invested more in R&D, with expenditures peaking at 218% of Alkermes' highest annual spend. However, 2022 marked a turning point when Alkermes dramatically increased its R&D investment by over 500% compared to its 2014 figures, surpassing Perrigo for the first time. This shift highlights Alkermes' strategic pivot towards innovation, potentially reshaping its market position. As the industry evolves, these investment trends could signal future breakthroughs and competitive advantages. Stay tuned as these companies continue to innovate and redefine the pharmaceutical landscape.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Alkermes plc
AbbVie Inc. vs Perrigo Company plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Genmab A/S or Perrigo Company plc: Who Invests More in Innovation?
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
R&D Spending Showdown: Alkermes plc vs Viridian Therapeutics, Inc.
Research and Development Investment: Alkermes plc vs MiMedx Group, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Perrigo Company plc and Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Perrigo Company plc vs Amicus Therapeutics, Inc.